Science Corporation has received European Union approval for its vision-restoring neural implant chip, marking a significant regulatory milestone for brain-computer interface technology. This approval facilitates the commercialization and broader clinical application of their neuroprosthetic solutions for restoring sight.
Background
Science Corporation is developing neural implants to restore vision in patients with degenerative eye diseases, leveraging direct cortical stimulation. EU regulatory approval is often a critical step for global expansion of advanced medical technologies.
- Source
- TechCrunch
- Published
- Jul 23, 2026 at 02:18 AM
- Score
- 7.0 / 10